PositoAI
a positivity index
Home Explore Actions Flows Indices News Watchlist Compare PosiDemy Screeners Insights
PosiFunda · Fundamentals

Modalis Therapeutics Corporation

Standard fundamentals

P/E, P/B, ROE, debt, growth and more (10)

Modalis Therapeutics Corporation made a loss over the last year. Modalis Therapeutics Corporation owes ¥0.21 for every ¥1 it owns. Modalis Therapeutics Corporation made a loss in each of the last two years.

Compared with Healthcare companies in Japan · latest annual results Dec 2025.

P/E ratio

Loss

Modalis Therapeutics Corporation made a loss over the last year, so its P/E ratio is not meaningful.

P/B ratio

1.14

The share price is 1.14 times Modalis Therapeutics Corporation's book value per share, lower than 68% of Healthcare companies in Japan.

Market cap

¥2.8 B

The total market value of all of Modalis Therapeutics Corporation's shares at today's price (share price × number of shares), smaller than 91% of Healthcare companies in Japan. PosiCap size class: Micro Cap.

Net worth (book value)

¥2.5 B

What Modalis Therapeutics Corporation would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).

Book value per share

¥23.70

Net worth divided by the number of shares. The share price of ¥27.00 is 1.1 times this, which is the P/B above.

Return on equity (ROE)

-72.2%

Modalis Therapeutics Corporation lost 72.2% of its shareholders' money over the last year, lower than 93% of Healthcare companies in Japan.

Owes vs Owns

0.21×

Modalis Therapeutics Corporation owes ¥0.21 for every ¥1 it owns (low), lower than 72% of Healthcare companies in Japan.

Dividend yield

None

Modalis Therapeutics Corporation does not currently pay a dividend.

Profit growth

Loss

Modalis Therapeutics Corporation made a loss in each of the last two years.

Interest cover

Not covered

Modalis Therapeutics Corporation's operating profit did not cover its interest costs in the year to Dec 2025.

Questions

How is P/B calculated on PositoAI?

P/B is market cap divided by net worth from the latest balance sheet. For Modalis Therapeutics Corporation: ¥2.8 B ÷ ¥2.5 B (30 Jun 2026) = 1.1.

What is Modalis Therapeutics Corporation's return on equity?

Modalis Therapeutics Corporation lost 72.2% of its shareholders' money over the last year, lower than 93% of Healthcare companies in Japan.

How much does Modalis Therapeutics Corporation owe compared with what it owns?

Modalis Therapeutics Corporation owes ¥0.21 for every ¥1 it owns (low), lower than 72% of Healthcare companies in Japan.

Does Modalis Therapeutics Corporation pay a dividend?

No. Modalis Therapeutics Corporation does not currently pay a dividend.

Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.

Disclaimer — PositoAI is a research and screening tool for educational and informational purposes. It is not investment advice or a recommendation to buy or sell any security or mutual fund. Scores and rankings are calculated by PositoAI's own method using publicly available data, which may be incomplete, delayed or inaccurate, and past performance does not indicate future results. AI summaries of company news may contain errors. PositoAI is not registered with the SEC, SEBI or any other regulatory authority. Please do your own research or consult a licensed financial advisor before investing.